Ebola Virus

Broadly acting antibodies found in plasma of Ebola survivors – study founds

ZMapp, an experimental therapy comprising three monoclonal antibodies, has shown promise in a clinical trial, but it targets only one of the five known species of Ebola virus.

Advertisements